Peer-reviewed veterinary case report
How canine interferon-gamma reduces skin inflammation signals in dog
By Shibata, Sanae et al.·Published in Veterinary dermatology·2011·The United Graduate School of Veterinary Sciences, Japan·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Effect of recombinant canine interferon-γ on granulocyte-macrophage colony-stimulating factor, transforming growth factor-β and CC chemokine ligand 17 mRNA transcription in a canine keratinocyte cell line (CPEK).
- Species:
- dog
Plain-English summary
A study found that a special treatment called recombinant canine interferon-gamma (rCaIFN-γ) may help dogs with atopic dermatitis, a skin condition that causes itching and inflammation. This treatment appears to work by reducing certain inflammatory signals in the skin cells of dogs. While it significantly lowered the production of a specific protein (GM-CSF) that contributes to inflammation, it did not affect other proteins involved in the condition. More research is needed to fully understand how this treatment works and its effectiveness in real-life cases.
People also search for: dog atopic dermatitis treatment · rCaIFN-γ for dogs · dog skin problems remedies
Abstract
Recombinant canine interferon-γ (rCaIFN-γ) produced by a baculovirus expression system has therapeutic efficacy against atopic dermatitis in dogs. Although the mechanism of action of rCaIFN-γ is not completely understood, rCaIFN-γ is thought to downregulate the activity of interleukin-4- and interleukin-5-producing T helper 2 cells. However, rCaIFN-γ may also act directly on canine keratinocytes by inhibiting the release of inflammatory mediators. In this study, we investigated the effects of rCaIFN-γ on cytokine and chemokine mRNA transcription in a canine keratinocyte cell line, CPEK. It was found that granulocyte-macrophage colony-stimulating factor (GM-CSF) mRNA transcription was significantly inhibited after treatment with rCaIFN-γ (P<0.001), whereas transforming growth factor-β and CC chemokine ligand 17 mRNA levels were unchanged. This study suggests that rCaIFN-γ may suppress GM-CSF production from canine keratinocytes, although further studies are required to confirm this.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/20860556/